Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 17, 2016 - Issue 7-8
Submit an article Journal homepage
1,182
Views
2
CrossRef citations to date
0
Altmetric
Report

Case report of concurrent Fabry disease and amyotrophic lateral sclerosis supports a common pathway of pathogenesis

Alexander M. BeerSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield and
,
Johnathan Cooper-KnockSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield and
,
Sakina FletcherSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield and
,
Sian Heledd Brown-WrightSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield and
,
T Pisharam NandakumarHull Royal Infirmary, Hull, UK
&
Pamela J. ShawSheffield Institute for Translational Neuroscience (SITraN), University of Sheffield and Correspondence[email protected]
Pages 614-616 | Received 21 Dec 2015, Accepted 28 Feb 2016, Published online: 20 Apr 2016

References

  • Tuttolomondo A, Pecoraro R, Simonetta I, Miceli S, Pinto A, Licata G. Anderson-Fabry Disease: A Multiorgan Disease. Current Pharmaceutical Design. 2013;19:5974–96.
  • MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. Journal of Medical Genetics. 2001;38:750–60.
  • Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031–41.
  • Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9orf72. Brain. 2012;135:751–64.
  • Bersano A, Lanfranconi S, Valcarenghi C, Bresolin N, Micieli G, Baron P. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy. Acta Neurologica Scandinavica. 2012;126:77–97.
  • Tuttolomondo A, Pecoraro R, Simonetta I, Miceli S, Arnao V, Licata G, et al. Neurological Complications of Anderson-Fabry Disease. Current Pharmaceutical Design. 2013l;19: 6014–30.
  • Chevrier M, Brakch N, Lesueur C, Genty D, Moll S, Djavaheri-Mergny M, et al. Autophagosome maturation is impaired in Fabry disease. Journal of Inherited Metabolic Disease. 2010;33:S126.
  • Nelson MP, Tse TE, O'Quinn DB, Percival SM, Jaimes EA, Warnock DG, et al. Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice. Acta Neuropathologica Communications. 2014;2:20.
  • Brady OA, Meng P, Zheng Y, Mao Y, Hu F. Regulation of TDP-43 aggregation by phosphorylation and p62/SQSTM1. J Neurochem. 2011;116: 248–59.
  • Li L, Zhang XJ, Le WD. Altered macroautophagy in the spinal cord of S0D1 mutant mice. Autophagy. 2008;4:290–3.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.